MedPath

Improving Smoking Cessation Quitlines: Pilot Study of Acceptance Therapy

Not Applicable
Completed
Conditions
Smoking
Interventions
Behavioral: Acceptance Therapy (ACT)
Other: Cognitive Behavioral Therapy (CBT)
Registration Number
NCT01525420
Lead Sponsor
Fred Hutchinson Cancer Center
Brief Summary

The purpose of this study is to demonstrate that Acceptance Therapy (ACT's) implementation outcomes are at least as good as those of traditional cognitive behavioral therapy (CBT).

Implementation outcomes:

* end of treatment and 6-month follow-up data retention rates;

* intervention implementation quality;

* number \& length of calls completed.

Comparison of each arm's implementation

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
121
Inclusion Criteria
  1. aged 18 and older;
  2. smokes at least 10 cigarettes daily and has done so for at least the past 12 months;
  3. wants to quit smoking in the next 30 days;
  4. willing to be randomly assigned to either group;
  5. willing and able to speak and read in English;
  6. willing and medically eligible to use nicotine replacement therapy (NRT),
  7. currently resides in the U.S., and expects to continue for at least 12 months;
  8. not participating in other smoking cessation interventions;
  9. has regular access to a telephone.
  10. has regular access to an email address.
Exclusion Criteria
  • The Exclusion criteria are the opposite of the Inclusion criteria listed above. In addition, the following exclusion criteria also apply:

    1. another member of household enrolled in the study;
    2. currently using medication or nicotine replacement products to help with quitting smoking;
    3. currently using any non-cigarette tobacco products;
    4. pregnant or breastfeeding;
    5. had a heart attack in last 30 days;
    6. within the last 6 months, diagnosed with angina, heart pain, or irregular heartbeat;
    7. serious adverse reactions to nicotine patches including anaphylaxis and related symptoms such as hives, respiratory difficulty, and/or angioedema.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ACTAcceptance Therapy (ACT)ACT: This is the experimental arm of the study. This included 5 weekly sessions of ACT therapy via telephone.
CBTCognitive Behavioral Therapy (CBT)CBT: This is the control arm of the study. This included 5 weekly sessions of CBT therapy via telephone.
Primary Outcome Measures
NameTimeMethod
Number of Participants Who Stopped Smoking by 6 Month Post Treatment6 months

30-Day point prevalence abstinence at 6 months post treatment

Secondary Outcome Measures
NameTimeMethod
7-day and 24-hour Point Prevalence Quit Rates6-month

7-day and 24-hour point prevalence quit rates

Trial Locations

Locations (1)

Fred Hutchinson Cancer Research Center

šŸ‡ŗšŸ‡ø

Seattle, Washington, United States

Ā© Copyright 2025. All Rights Reserved by MedPath